Skip to main content

Bio-Path Holdings, Inc.

BPTH
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001133818

No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Bio-Path Holdings, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of BPTH: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders17170
Shares392.6K412.2K+19.6K (+5.0%)
Value$1.51M$1.59M+$86.0K (+5.7%)

New holders (2)

Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to BPTH in Q2 2022
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC18,000$70.0K0.00%
Dimensional Fund Advisors LP12,960$50.0K0.00%

Sold out (2)

Institutions that held Bio-Path Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of BPTH in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Virtu Financial LLC10,012$38.0K
Money Concepts Capital Corp300$1.00K